Deaths to cancer in Europe: What is to be expected for 2017?
Information on the author and / or the expert adviser can be found at the end of the article.
Researchers expect a drop in the mortality rate in most cancers. Only in pancreatic cancer and lung cancer is the trend different.
Before the official numbers of cancer and cancer-related deaths are known for a particular year, it usually takes some time. However, scientists are able to determine the trends in the development of diseases and their deaths with special screening programs. A research group has just published the figures for the year 2017 in the European Union (EU), published in the journal Annals of Oncology.
For their analysis, the researchers relied on the disease and mortality rates from 1970 to 2012 for certain countries and the EU as a whole. They calculated an increase in absolute deaths of cancer in the EU in 2017 compared to 2012 by three percent. On the other hand, the mortality rate will decrease in both sexes – in men by about eight per cent, in women by around three and a half per cent.
For all types of cancer, the mortality rates are lower, with the exception of pancreatic cancer in both sexes and lung cancer in women. While the mortality rates of pancreatic cancer in men remain stable, it increases by 3.5 per cent in women. In 2017, the mortality rate of lung cancer in women rose by five percent compared to 2012. It is higher with 14.6 deaths per 100,000 than that of breast cancer with 14.0 per 100,000. Only in younger women aged 25 to 44 years are more favorable trends observed with regard to pulmonary cancer.
In men, the mortality rate for lung cancer is about eleven percent lower than in 2012. A drop in lung cancer cases is observed here in all age groups. The difference in the development of deaths from lung cancer in men and women is attributed to the differences in smoking patterns: women were much more sensitive to smoking with men, which is why the health effects are noticeable later. In the young generation of 25 to 44-year-olds, the mortality rates are comparable to lung cancer in men with 1.2 per 100,000 and women with 1.4 per 100,000.